Cargando…
SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease
Patients with severe chronic graft-versus-host disease (cGVHD) always experience debilitating tissue injury and have poorer quality of life and shorter survival time. The early stage of cGVHD is characterized by inflammation, which eventually leads to extensive tissue fibrosis in various organs, suc...
Autores principales: | Lu, Run-qing, Zhang, Yin-yin, Zhao, Hai-qiu, Guo, Rong-qun, Jiang, Zhong-xing, Guo, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866649/ https://www.ncbi.nlm.nih.gov/pubmed/35222400 http://dx.doi.org/10.3389/fimmu.2022.822303 |
Ejemplares similares
-
Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease
por: Hong, Chao, et al.
Publicado: (2021) -
Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential
por: Bronk, Crystina C., et al.
Publicado: (2012) -
Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
por: Betts, Brian C., et al.
Publicado: (2019) -
T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021) -
NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)